Literature DB >> 35583040

Post-Acute Sequelae of SARS-CoV-2 Infection.

Mandy Schulz, Sandra Mangiapane, Martin Scherer, Christian Karagiannidis, Thomas Czihal.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35583040      PMCID： PMC9215269          DOI： 10.3238/arztebl.m2022.0134

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   8.251


× No keyword cloud information.
  4 in total

1.  Attributes and predictors of long COVID.

Authors:  Sebastien Ourselin; Tim Spector; Claire J Steves; Carole H Sudre; Benjamin Murray; Thomas Varsavsky; Mark S Graham; Rose S Penfold; Ruth C Bowyer; Joan Capdevila Pujol; Kerstin Klaser; Michela Antonelli; Liane S Canas; Erika Molteni; Marc Modat; M Jorge Cardoso; Anna May; Sajaysurya Ganesh; Richard Davies; Long H Nguyen; David A Drew; Christina M Astley; Amit D Joshi; Jordi Merino; Neli Tsereteli; Tove Fall; Maria F Gomez; Emma L Duncan; Cristina Menni; Frances M K Williams; Paul W Franks; Andrew T Chan; Jonathan Wolf
Journal:  Nat Med       Date:  2021-03-10       Impact factor: 53.440

2.  Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.

Authors:  Lars Christian Lund; Jesper Hallas; Henrik Nielsen; Anders Koch; Stine Hasling Mogensen; Nikolai Constantin Brun; Christian Fynbo Christiansen; Reimar Wernich Thomsen; Anton Pottegård
Journal:  Lancet Infect Dis       Date:  2021-05-10       Impact factor: 25.071

3.  Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.

Authors:  Shin Jie Yong
Journal:  Infect Dis (Lond)       Date:  2021-05-22

Review 4.  A clinical case definition of post-COVID-19 condition by a Delphi consensus.

Authors:  Joan B Soriano; Srinivas Murthy; John C Marshall; Pryanka Relan; Janet V Diaz
Journal:  Lancet Infect Dis       Date:  2021-12-21       Impact factor: 71.421
  4 in total
  1 in total

1.  Post-COVID Syndrome- More Questions Than Answers.

Authors:  Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2022-03-11       Impact factor: 8.251
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.